Detalhe da pesquisa
1.
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Lancet
; 400(10362): 1513-1521, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522207
2.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Lancet Oncol
; 15(2): 201-12, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24360787
3.
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Front Oncol
; 14: 1296576, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357205
4.
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
J Clin Oncol
; 42(10): 1135-1145, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190578
5.
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Trials
; 21(1): 96, 2020 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952545